Ametek (AME) Q2 Earnings In Line, Revenues Miss Estimates

AME

AMETEK Inc. (AME - Free Report) is a leading worldwide manufacturer of electronic appliances and electromechanical devices. AMETEK sells its products globally through two major operating groups, the Electronic Instruments Group (“EIG”) and the Electromechanical Group (“EMG”).

AMETEK’s strong execution of its four core growth strategies of operational excellence, global market expansion, new product development, and strategic acquisitions continues to play an important role in driving its growth. This in combination with its excellent backlog and strong portfolio of businesses will help the company post better results in the upcoming quarter.

Due to this, investors are eagerly awaiting AMETEK’s earnings report in order to set the record straight and to give some guidance on where this company is heading and are these factors effectively contributing.

However, recent earnings estimate revision activity for AME has been limited as the consensus estimate for the stock has seen just one negative revision over the past month.

Currently, AME has a Zacks Rank #4 (Sell), but that could definitely change following the company’s earnings report which was just released. We have highlighted some of the key stats from this just-revealed announcement below:

Earnings: AME reported earnings of 59 cents which are in-line with the Zacks Consensus Estimate.

Revenue:AMETEK missed on revenues. It posted revenues of $977.7 million, compared to our consensus estimate of $990.0 million.

Key Stats: The company reported operating cash flow of $189 million, an increase of 16% year over year.

Check back later for our full write up on this AME earnings report later!

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>